Bari – Italian researchers have successfully used the dexamethasone implant Ozurdex for the proactive treatment of diabetic macular edema (DME) or retinal vein occlusion (RVO) (British Journal of Ophthalmology 2026; DOI: 10.1136/bjo-2025-328550). Clinically significant improvements in visual acuity were observed. Typically...
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Bari – Italian researchers have successfully used the dexamethasone implant Ozurdex for the proactive treatment of diabetic macular edema (DME) or retinal vein occlusion (RVO) (British Journal of Ophthalmology 2026; DOI: 10.1136/bjo-2025-328550). Clinically significant improvements in visual acuity were observed. Typically...